Heinicke U - Search Results

1

BCL-x_L-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

Faqar-Uz-Zaman SF, Heinicke U, Meister MT, Vogler M, Fulda S. Faqar-Uz-Zaman SF, et al. Among authors: heinicke u. Cancer Lett. 2018 Jan 1;412:131-142. doi: 10.1016/j.canlet.2017.09.025. Epub 2017 Sep 23. Cancer Lett. 2018. PMID: 28947136

2

Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.

Heinicke U, Fulda S. Heinicke U, et al. Cancer Lett. 2014 Aug 28;351(1):50-8. doi: 10.1016/j.canlet.2014.04.021. Epub 2014 May 6. Cancer Lett. 2014. PMID: 24814395

3

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo.

Gajer JM, Furdas SD, Gründer A, Gothwal M, Heinicke U, Keller K, Colland F, Fulda S, Pahl HL, Fichtner I, Sippl W, Jung M. Gajer JM, et al. Among authors: heinicke u. Oncogenesis. 2015 Feb 9;4(2):e137. doi: 10.1038/oncsis.2014.51. Oncogenesis. 2015. PMID: 25664930 Free PMC article.

4

Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.

Unland R, Clemens D, Heinicke U, Potratz JC, Hotfilder M, Fulda S, Wardelmann E, Frühwald MC, Dirksen U. Unland R, et al. Among authors: heinicke u. Anticancer Drugs. 2015 Sep;26(8):843-51. doi: 10.1097/CAD.0000000000000256. Anticancer Drugs. 2015. PMID: 26053276

5

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.

Heinicke U, Kupka J, Fulda S. Heinicke U, et al. Oncotarget. 2015 Nov 10;6(35):37836-51. doi: 10.18632/oncotarget.6097. Oncotarget. 2015. PMID: 26473375 Free PMC article.

6

Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma.

Heinicke U, Kupka J, Fichter I, Fulda S. Heinicke U, et al. Oncogene. 2016 Jul 14;35(28):3729-41. doi: 10.1038/onc.2015.440. Epub 2015 Nov 30. Oncogene. 2016. PMID: 26616861

7

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival.

Thole TM, Lodrini M, Fabian J, Wuenschel J, Pfeil S, Hielscher T, Kopp-Schneider A, Heinicke U, Fulda S, Witt O, Eggert A, Fischer M, Deubzer HE. Thole TM, et al. Among authors: heinicke u. Cell Death Dis. 2017 Mar 2;8(3):e2635. doi: 10.1038/cddis.2017.49. Cell Death Dis. 2017. PMID: 28252645 Free PMC article.

8

BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.

Heinicke U, Haydn T, Kehr S, Vogler M, Fulda S. Heinicke U, et al. Oncogene. 2018 Sep;37(39):5325-5339. doi: 10.1038/s41388-018-0212-5. Epub 2018 Jun 1. Oncogene. 2018. PMID: 29858601

9

Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.

von Knethen A, Heinicke U, Weigert A, Zacharowski K, Brüne B. von Knethen A, et al. Among authors: heinicke u. Int J Mol Sci. 2020 Mar 29;21(7):2356. doi: 10.3390/ijms21072356. Int J Mol Sci. 2020. PMID: 32235291 Free PMC article. Review.

10

Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.

Heinicke U, Adam E, Sonntagbauer M, von Knethen A, Zacharowski K, Neb H. Heinicke U, et al. Crit Care. 2020 Jul 9;24(1):409. doi: 10.1186/s13054-020-03143-7. Crit Care. 2020. PMID: 32646469 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters